Back to Journals » International Journal of General Medicine » Volume 16

KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy

Total article views   HTML views PDF downloads Totals
2,085 Dovepress* 1,984+ 51 2,035
PubMed Central* 101 59 160
Totals 2,085 110 2,195
*Since 21 August 2023

View citations on PubMed and Google Scholar